- Home
- Equipment
- north america
- blood disease
Refine by
Blood Disease Equipment Supplied In North America
16 equipment items found
Manufactured by:Editas Medicine based inCambridge, MASSACHUSETTS (USA)
EDIT-301 is an experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). EDIT-301 consists of patient-derived CD34+ hematopoietic stem and progenitor cells edited at the gamma globin gene (HBG1 and HBG2) promoters, where naturally occurring fetal hemoglobin (HbF) inducing ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
Our novel protocols will use small molecules to make platelets, which will allow production of platelets at scale. We will use our platelets as the foundation for a cell therapy for the treatment of blood loss and various blood diseases and disorders, which we are developing. ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are developing human red blood cells (Erythrocytes) from induced pluripotent stem cells (iPSCs) in a two-step process (iPSCs to HSCs and HSCs to Erythrocytes). Our novel protocols will use small molecules to make red blood cells, which will allow production of red blood cells at scale. We will use our red blood cells as the ...
Manufactured by:Rotech Healthcare Inc. based inOrlando, FLORIDA (USA)
During sleep, especially during the deepest stages of sleep (called REM sleep), the muscles in the back of the throat relax. This causes the upper airway to become smaller. Sleep Apnea is a sleep disorder where the upper airway collapses, causing a blockage of air movement into the lungs and stopping airflow for several seconds or more. An apnea is a pause in breathing, lasting at least 10 ...
Manufactured by:Stanford Chemicals Company based inLake Forest, CALIFORNIA (USA)
Losartan competes with the binding of angiotensin II to AT1 receptors. The concentration that inhibits 50% of the binding of angiotensin II (IC50) is 20 nM. Losartan (40 μM) affects ISC but prevents the effect of ANGII on ISC. Losartan significantly reduces Ang II-mediated cell proliferation in endometrial cancer cells. The combination of losartan and anti-miR-155 has a significantly greater ...
Manufactured by:Ativa Medical based inShoreview, MINNESOTA (USA)
Ativa's Diagnostic Workstation with a miniaturized flow-cytometer can measure the innate immune response cells in the blood. In COVID-19, Natural-Killer Cell activation occurs within hours of first infection, these cells fight the Virus in the lungs. Miniaturized low-cost diagnostic tests Immediate lab-quality results Advanced A.I. disease screening …all ...
Manufactured by:Haier Biomedical based inQingdao, CHINA
A versatile low-temperature freezer installed in hospitals, blood stations, diseases control & prevention centers, research institutions, bioscience laboratories and medical laboratories. It is suitable for storing a wide variety of biological products including viruses, bacteria, red blood cells, white blood cells, skin, ...
Manufactured by:C2N Diagnostics based inSt. Louis, MISSOURI (USA)
The PrecivityAD™ test is an innovative new blood test intended for use in patients with cognitive impairment. The test aims to help physicians better determine the presence or absence of amyloid plaques in the brain, a hallmark sign of Alzheimer’s ...
Manufactured by:KORU Medical Systems based inMahwah, NEW JERSEY (USA)
Chronic inflammatory demyelinating polyneuropathy, or CIDP, is a rare disorder characterized by gradually increasing sensory loss and weakness associated with loss of reflexes. This is caused by an autoimmune process in which the body’s own immune system doesn’t recognize its nerve fibers and attacks them. This leads to inflammation of nerve roots and peripheral nerves, as well as ...
Manufactured by:PRN Pharmacal based inPensacola, FLORIDA (USA)
The most commonly reported side effects were vomiting, loss of appetite, diarrhea, excessive salivation, agitation, tiredness, vocalization, confusion, increased water consumption, weight loss, weakness, fever, panting, and reversible changes in skin color (flushing or bright pink). Abnormal gait, seizures or tremors, as well as liver enzyme elevations, kidney failure, blood in urine and urine ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as the ...
by:UNITY Biotechnology based inSouth San Francisco, CALIFORNIA (USA)
UBX1325, a potent Bcl-xL inhibitor, is in clinical development for the treatment of age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX1325 is designed to selectively eliminate the senescent cells accumulating in diseased blood vessels of the eye. This ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
RN-1 dihydrochloride is a potent, brain-penetrant, irreversible and selective lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 of 70 nM. RN-1 dihydrochloride exhibits selectivity for LSD1 over MAO-A and MAO-B with IC50 values of 0.51 μM and 2.785 μM ...
Manufactured by:Vitruvian BioMedical, Inc. based inAddison, TEXAS (USA)
VITRUVIAN has obtained the Exclusive Global License for a Therapeutic Vaccine for the Prevention of Alzheimer's Disease. YM7555 - Alzheimer’s Disease Therapeutic Vaccine targeting ABeta and TAU. VITRUVIAN has received an Exclusive Global License for YM7555 which is a Therapeutic Vaccine technology for the prevention of Alzheimer’s Disease. The vaccine is a gene-based (DNA) vaccine, ...
Manufactured by:KORU Medical Systems based inMahwah, NEW JERSEY (USA)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, chronic, life-threatening blood disorder characterized by the complement-mediated destruction (hemolysis) of oxygen-carrying red blood cells. The disease is caused by a genetic mutation in the DNA and causes red blood cells to be missing a critical protein responsible for ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a humanized recombinant anti-CD6 monoclonal antibody (MAb) targeting the extracellular SRCR distal domain 1 of CD6. Itolizumab reduces T-cell proliferation and inhibits the production of pro-inflammatory cytokines, such as INF-γ, TNFα and IL-6. Itolizumab can be used in the research of psoriasis, rheumatoid arthritis (RA), ...